Merck agrees to acquire Silence Therapeutics for $20 per ADS in a $1.3 billion equity deal, adding Divesiran to its rare ...

Mako Mining recovers 12,743 ounces of gold in Q3 2026, generating $50 million in revenue while advancing Moss, Mt. Hamilton ...

Chord Energy reports Q3 2026 production of 290,500–290,900 barrels daily, $205 million in share repurchases and a $550 ...

AST SpaceMobile supports four European telecom operators exploring a satellite spectrum bid, targeting connectivity ...

Cleveland-Cliffs reports $612 million in Q3 2026 adjusted EBITDA, $5.6 billion revenue and forecasts over $4 billion in ...

Biodesix partners with Vanderbilt to develop an AI-powered lung nodule risk test, with RSNA data due December 2026 and ...

AbbVie reports 40.5% endoscopic remission with ABBV-466 at Week 24 in its Phase 2a Crohn's disease trial, compared with 22.4% ...

Brent crude falls 2.08% to $107.57 as Trump waives Russia sanctions, while WTI drops to $99.46 amid continuing Middle East ...

OpenWorld signs a Blocksight merger agreement to support proposed tokenized financing programs of up to $1.13 billion with ...

Oculis completes randomization of 176 patients in its PREDICT-1 Licaminlimab dry eye trial, with topline results expected ...

Peoples Bancorp of North Carolina reports Q3 2026 net earnings of $5.7 million, EPS of $1.05 and higher net interest income ...

Werner Enterprises expects third-quarter 2026 revenue of $946 million to $951 million, compared with $933.9 million in the preceding quarter. The company projects GAAP diluted earnings per share of $0 ...